A comparison of intratracheal and intravenous administration of gentamicin during liquid ventilation

European Journal of Pediatrics
M A ZelinkaT H Shaffer

Abstract

Pulmonary absorption of aminoglycosides is poor with intravenous administration, but may be enhanced by direct intratracheal administration of these drugs using perfluorochemical liquid ventilation (LV). To test this hypothesis, gentamicin sulfate was administered to two groups of newborn lambs during LV. Serum and lung tissue levels of gentamicin were compared after either pulmonary intratracheal (IT) or intravenous (IV) routes of administration. Serial serum levels of gentamicin were obtained every 15 min for the 1st h, every 30 min for the 2nd h, and then hourly until sacrifice (maximum 6 h). At sacrifice, representative samples of each lung lobe were homogenized and analyzed for tissue gentamicin content. At 1 h, serum gentamicin levels were similar in both groups: IT administration levels were 3.7 +/- 0.55 SE micrograms/ml and IV levels were 3.5 +/- 0.85 SE micrograms/ml. The peak serum gentamicin level of 4.8 +/- 0.8 SE micrograms/ml for the pulmonary administration group occurred 1.5 h after administration. Lung tissue levels of gentamicin for IT administration (4.04 +/- 0.62 SE micrograms/g) were significantly greater than for IV administration (1.75 +/- 0.33 SE micrograms/g; P < 0.05). There were no significant differe...Continue Reading

Citations

May 25, 2005·Paediatric Respiratory Reviews·Marla R Wolfson, Thomas H Shaffer
Mar 13, 2002·Critical Care Medicine·Eric W DicksonGary V Doern
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·A R FranzH D Hummler
Nov 2, 2011·Oman Medical Journal·Qutaiba A Tawfic, Rajini Kausalya
Aug 21, 2007·The British Journal of Radiology·R TiruvoipatiG J Peek
May 11, 2007·Expert Opinion on Drug Delivery·Hans-Joachim Lehmler
Oct 14, 2010·Experimental Lung Research·Rolf DembinskiRalf Kuhlen
Dec 22, 1999·Respiratory Medicine·A B CullenT H Shaffer
Aug 26, 1998·Pediatric Pulmonology·M R WolfsonT H Shaffer
Feb 22, 2001·Journal of Applied Physiology·T F MillerM R Wolfson
Mar 27, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Giuseppe A Marraro
May 27, 2016·Clinical Microbiology Reviews·Eric WenzlerLarry H Danziger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.